Back to Search Start Over

Augmented transgene expression in transformed cells using a parvoviral hybrid vector.

Authors :
Krüger L
Eskerski H
Dinsart C
Cornelis J
Rommelaere J
Haberkorn U
Kleinschmidt JA
Source :
Cancer gene therapy [Cancer Gene Ther] 2008 Apr; Vol. 15 (4), pp. 252-67. Date of Electronic Publication: 2008 Jan 18.
Publication Year :
2008

Abstract

Autonomous parvoviruses possess an intrinsic oncotropism based on viral genetic elements controlling gene expression and genome replication. We constructed a hybrid vector consisting of the H1 parvovirus-derived expression cassette comprising the p4 promoter, the ns1 gene and the p38 promoter flanked by the adeno-associated viruses 2 (AAV2) inverted terminal repeats and packaged into AAV2 capsids. Gene transduction using this vector could be stimulated by coinfection with adenovirus, by irradiation or treatment with genotoxic agents, similar to standard AAV2 vectors. However, the latter were in most cases less efficient in gene transduction than the hybrid vector. With the new vector, tumor cell-selective increase in transgene expression was observed in pairs of transformed and non-transformed cells, leading to selective killing of the transformed cells after expression of a prodrug-converting enzyme. Preferential gene expression in tumor versus normal liver tissue was also observed in vivo in a syngeneic rat model. Comparative transduction of a panel of different tumor cell lines with the H1 and the H1/AAV hybrid vector showed a preference of each vector for distinct cell types, probably reflecting the dependence of the viral tropism on capsid determinants.

Details

Language :
English
ISSN :
1476-5500
Volume :
15
Issue :
4
Database :
MEDLINE
Journal :
Cancer gene therapy
Publication Type :
Academic Journal
Accession number :
18202715
Full Text :
https://doi.org/10.1038/sj.cgt.7701113